Comparative effect of intraurethral clobetasol and tacrolimus in lichen sclerosus-associated urethral stricture disease

Background: Management of urethral stricture related to lichen sclerosus (LS) is now gradually changing from surgical to nonsurgical due to availability of anti-inflammatory agents such as corticosteroids and calcineurin inhibitors. We determined the clinical impact of these agents in such patients...

Full description

Bibliographic Details
Main Authors: Sunirmal Choudhury, Eeshansh Khare, Dilip Kumar Pal
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2023-01-01
Series:Urology Annals
Subjects:
Online Access:http://www.urologyannals.com/article.asp?issn=0974-7796;year=2023;volume=15;issue=2;spage=174;epage=179;aulast=Choudhury
_version_ 1797775390226251776
author Sunirmal Choudhury
Eeshansh Khare
Dilip Kumar Pal
author_facet Sunirmal Choudhury
Eeshansh Khare
Dilip Kumar Pal
author_sort Sunirmal Choudhury
collection DOAJ
description Background: Management of urethral stricture related to lichen sclerosus (LS) is now gradually changing from surgical to nonsurgical due to availability of anti-inflammatory agents such as corticosteroids and calcineurin inhibitors. We determined the clinical impact of these agents in such patients on outpatient department basis in terms of improvement in symptoms on International Prostate Symptom Score (IPSS), external skin appearance, and maximum urinary flow rate (Qmax). Materials and Methods: Eighty patients of meatal stenosis and penile urethral stricture with histopathologically proven LS were divided into two groups, and clinical and predetermined parameters such as Qmax, IPSS, and changes in external appearance were compared between these groups after 3 months of topical and intraurethral application of clobetasol and tacrolimus with self-calibration. Results: A significant intragroup difference was noted in IPSS (P < 0.001) as well as Qmax (P < 0.001); postintervention intergroup difference in IPSS was not significant (P = 0.94) and however postintervention intergroup difference in Qmax was significant in favor of clobetasol (P = 0.007). A significantly increased number of additional procedures were done in the group receiving intraurethral tacrolimus (P = 0.0473) with significantly less number of skin complication in the group with topically applied clobetasol (P = 0.003). Conclusion: Though both clobetasol and tacrolimus, improved symptom score, Qmax and local external appearance yet topical and intra-urethral clobetasol application via urethral self calibration seems to be better option for lichen sclerosus related urethral stricture in terms cost and local complications.
first_indexed 2024-03-12T22:35:01Z
format Article
id doaj.art-f1481bb263ae47b2854f22c5d48e5c24
institution Directory Open Access Journal
issn 0974-7796
0974-7834
language English
last_indexed 2024-03-12T22:35:01Z
publishDate 2023-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Urology Annals
spelling doaj.art-f1481bb263ae47b2854f22c5d48e5c242023-07-21T13:08:56ZengWolters Kluwer Medknow PublicationsUrology Annals0974-77960974-78342023-01-0115217417910.4103/ua.ua_45_22Comparative effect of intraurethral clobetasol and tacrolimus in lichen sclerosus-associated urethral stricture diseaseSunirmal ChoudhuryEeshansh KhareDilip Kumar PalBackground: Management of urethral stricture related to lichen sclerosus (LS) is now gradually changing from surgical to nonsurgical due to availability of anti-inflammatory agents such as corticosteroids and calcineurin inhibitors. We determined the clinical impact of these agents in such patients on outpatient department basis in terms of improvement in symptoms on International Prostate Symptom Score (IPSS), external skin appearance, and maximum urinary flow rate (Qmax). Materials and Methods: Eighty patients of meatal stenosis and penile urethral stricture with histopathologically proven LS were divided into two groups, and clinical and predetermined parameters such as Qmax, IPSS, and changes in external appearance were compared between these groups after 3 months of topical and intraurethral application of clobetasol and tacrolimus with self-calibration. Results: A significant intragroup difference was noted in IPSS (P < 0.001) as well as Qmax (P < 0.001); postintervention intergroup difference in IPSS was not significant (P = 0.94) and however postintervention intergroup difference in Qmax was significant in favor of clobetasol (P = 0.007). A significantly increased number of additional procedures were done in the group receiving intraurethral tacrolimus (P = 0.0473) with significantly less number of skin complication in the group with topically applied clobetasol (P = 0.003). Conclusion: Though both clobetasol and tacrolimus, improved symptom score, Qmax and local external appearance yet topical and intra-urethral clobetasol application via urethral self calibration seems to be better option for lichen sclerosus related urethral stricture in terms cost and local complications.http://www.urologyannals.com/article.asp?issn=0974-7796;year=2023;volume=15;issue=2;spage=174;epage=179;aulast=Choudhuryclobetasolinternational prostate symptom scorelichen sclerosustacrolimusurethral strictureuroflowmetry
spellingShingle Sunirmal Choudhury
Eeshansh Khare
Dilip Kumar Pal
Comparative effect of intraurethral clobetasol and tacrolimus in lichen sclerosus-associated urethral stricture disease
Urology Annals
clobetasol
international prostate symptom score
lichen sclerosus
tacrolimus
urethral stricture
uroflowmetry
title Comparative effect of intraurethral clobetasol and tacrolimus in lichen sclerosus-associated urethral stricture disease
title_full Comparative effect of intraurethral clobetasol and tacrolimus in lichen sclerosus-associated urethral stricture disease
title_fullStr Comparative effect of intraurethral clobetasol and tacrolimus in lichen sclerosus-associated urethral stricture disease
title_full_unstemmed Comparative effect of intraurethral clobetasol and tacrolimus in lichen sclerosus-associated urethral stricture disease
title_short Comparative effect of intraurethral clobetasol and tacrolimus in lichen sclerosus-associated urethral stricture disease
title_sort comparative effect of intraurethral clobetasol and tacrolimus in lichen sclerosus associated urethral stricture disease
topic clobetasol
international prostate symptom score
lichen sclerosus
tacrolimus
urethral stricture
uroflowmetry
url http://www.urologyannals.com/article.asp?issn=0974-7796;year=2023;volume=15;issue=2;spage=174;epage=179;aulast=Choudhury
work_keys_str_mv AT sunirmalchoudhury comparativeeffectofintraurethralclobetasolandtacrolimusinlichensclerosusassociatedurethralstricturedisease
AT eeshanshkhare comparativeeffectofintraurethralclobetasolandtacrolimusinlichensclerosusassociatedurethralstricturedisease
AT dilipkumarpal comparativeeffectofintraurethralclobetasolandtacrolimusinlichensclerosusassociatedurethralstricturedisease